Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gan-Liang Tan

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
BMC Nephrology|December 20, 2022
Risk assessment of failure during transitioning from in-centre to home haemodialysisSabrina-Wong-Peixin Haroon, Titus-Wai-Leong Lau, Gan Liang Tan, et al.
International Journal of Pharmaceutics|June 11, 2018
A new therapeutic avenue for bronchiectasis: Dry powder inhaler of ciprofloxacin nanoplex exhibits superior ex vivo mucus permeability and antibacterial efficacy to its native ciprofloxacin counterpartThe-Thien Tran, Celine Vidaillac, Hong Yu, et al.
The European Respiratory Journal|June 9, 2018
Immunological corollary of the pulmonary mycobiome in bronchiectasis: the CAMEB studyMicheál Mac Aogáin, Ravishankar Chandrasekaran, Albert Yick Hou Lim, et al.
American Journal of Respiratory and Critical Care Medicine|September 29, 2018
Distinct "Immunoallertypes" of Disease and High Frequencies of Sensitization in Non-Cystic Fibrosis BronchiectasisMicheál Mac Aogáin, Pei Yee Tiew, Albert Yick Hou Lim, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
BMC Nephrology|December 20, 2022
Risk assessment of failure during transitioning from in-centre to home haemodialysisSabrina-Wong-Peixin Haroon, Titus-Wai-Leong Lau, Gan Liang Tan, et al.
International Journal of Pharmaceutics|June 11, 2018
A new therapeutic avenue for bronchiectasis: Dry powder inhaler of ciprofloxacin nanoplex exhibits superior ex vivo mucus permeability and antibacterial efficacy to its native ciprofloxacin counterpartThe-Thien Tran, Celine Vidaillac, Hong Yu, et al.
The European Respiratory Journal|June 9, 2018
Immunological corollary of the pulmonary mycobiome in bronchiectasis: the CAMEB studyMicheál Mac Aogáin, Ravishankar Chandrasekaran, Albert Yick Hou Lim, et al.
American Journal of Respiratory and Critical Care Medicine|September 29, 2018
Distinct "Immunoallertypes" of Disease and High Frequencies of Sensitization in Non-Cystic Fibrosis BronchiectasisMicheál Mac Aogáin, Pei Yee Tiew, Albert Yick Hou Lim, et al.
Pageof 2